Market Closed -
BME
11:35:26 2024-04-26 am EDT
5-day change
1st Jan Change
2.58
EUR
+2.38%
+1.98%
+14.67%
Sales 2022
274M
293M
Sales 2023
318M
340M
Capitalization
177M
190M
Net income 2022
8M
8.55M
Net income 2023
9M
9.62M
EV / Sales 2022
0.82
x
Net Debt
2022
54.76M
58.55M
Net Debt
2023
47.92M
51.23M
EV / Sales 2023
0.71
x P/E ratio 2022
21.9
x
P/E ratio 2023
18.8
x
Employees
1,331
Yield 2022
1.83%
Yield 2023
-
Free-Float
19.99%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024
Mar. 13
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 29
CI
Spain’s Reig Jofre Names New CFO
Dec. 20
MT
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-14
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
23-07-28
CI
Transcript : Laboratorio Reig Jofre, S.A., Q4 2022 Earnings Call, Mar 07, 2023
23-03-07
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
23-02-28
CI
Why Europe's drug shortages may get worse
23-02-08
RE
Reig Jofre JV Inks Deal with Indian Pharmaceutical to Commercialize Biosimilar Medicine
22-11-02
MT
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-14
CI
Laboratorio Reig Jofre, S.A.(BME:RJF) dropped from S&P Global BMI Index
22-09-19
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
22-07-29
CI
Laboratorio Reig Jofre, S.A.s Equity Buyback announced on July 18, 2019 has Expired. The company has repurchased 74,107 shares, representing 0.1% for 0.26 million.
22-04-23
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
22-02-28
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021
21-10-29
CI
More news
1 day +2.38%
1 week +1.98%
Current month +3.61%
1 month +3.20%
3 months +8.40%
6 months +17.27%
Current year +14.67%
More quotes
Managers
Title Age Since
Chief Executive Officer
56
05-12-31
Chief Tech/Sci/R&D Officer
-
02-12-31
Chief Operating Officer
52
02-12-31
Members of the board
Title Age Since
Chief Executive Officer
56
05-12-31
Director/Board Member
-
14-12-30
Director/Board Member
-
14-12-30
More insiders
Date
Price
Change
Volume
24-04-26
2.58
+2.38%
8,932
24-04-25
2.52
0.00%
4,940
24-04-24
2.52
-0.40%
2,788
24-04-23
2.53
+0.40%
3,071
24-04-22
2.52
-0.40%
20,523
Delayed Quote
BME, April 26, 2024 at 11:35 am EDT
More quotes
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
More about the company
1st Jan change
Capi.
+14.67% 213M +25.83% 653B +27.00% 556B -6.76% 354B +20.34% 331B +3.00% 296B +13.09% 233B +5.46% 201B -9.61% 193B -6.26% 144B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1